Skip to main content
Erschienen in: Japanese Journal of Ophthalmology 4/2018

30.04.2018 | Laboratory Investigation

Gene expression changes in the retina after systemic administration of aldosterone

verfasst von: Aoi Ono, Kazuyuki Hirooka, Yuki Nakano, Eri Nitta, Akira Nishiyama, Akitaka Tsujikawa

Erschienen in: Japanese Journal of Ophthalmology | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Retinal ganglion cell (RGC) loss associated with thinning of the retinal nerve fiber layer without elevated intraocular pressure (IOP) occurs after the systemic administration of aldosterone. Since it is important to determine the mechanism of cell death independent of the IOP, we examined gene expression changes in the retina after the systemic administration of aldosterone.

Methods

Following subcutaneous implantation of an osmotic minipump into the mid-scapular region of rats, we administered an 80 μg/kg/day dose of aldosterone. Differences in the gene expression in the retina between normal rats and aldosterone-treated rats were investigated using microarrays. Real-time PCR was used to confirm the differential expression.

Results

Analysis of the microarray data sets revealed the upregulation of 24 genes and the downregulation of 24 genes of key apoptosis-specific genes. Real-time PCR revealed 4 genes (Cdkn1a, Tbox5, Pf4, Vdr) were upregulated while 12 genes (Acvr1c, Asns, Bard1, Card9, Crh, Fcgr1a, Inhba, Kcnh8, Lck, Phlda1, Ptprc, Sh3rf1) were downregulated.

Conclusions

Significant increases and decreases were noted in several genes after the systemic administration of aldosterone. Further studies will need to be undertaken in order to definitively clarify the role of these genes in the eyes of animals with normal-tension glaucoma.
Literatur
1.
Zurück zum Zitat Levene RZ. Low tension glaucoma: a critical review and new material. Surv Ophthalmol. 1980;24:621–64.CrossRefPubMed Levene RZ. Low tension glaucoma: a critical review and new material. Surv Ophthalmol. 1980;24:621–64.CrossRefPubMed
3.
Zurück zum Zitat Cartwright MJ, Anderson DR. Correlation of asymmetric damage with asymmetric intraocular pressure in normal-tension glaucoma (low-tension glaucoma). Arch Ophthalmol. 1988;106:898–900.CrossRefPubMed Cartwright MJ, Anderson DR. Correlation of asymmetric damage with asymmetric intraocular pressure in normal-tension glaucoma (low-tension glaucoma). Arch Ophthalmol. 1988;106:898–900.CrossRefPubMed
4.
Zurück zum Zitat Crichton A, Drance SM, Douglas GR, Schulzer M. Unequal intraocular pressure and its relation to asymmetric visual field defects in low-tension glaucoma. Ophthalmology. 1989;96:1312–4.CrossRefPubMed Crichton A, Drance SM, Douglas GR, Schulzer M. Unequal intraocular pressure and its relation to asymmetric visual field defects in low-tension glaucoma. Ophthalmology. 1989;96:1312–4.CrossRefPubMed
5.
Zurück zum Zitat Abedin S, Simmons RJ, Grant WM. Progressive low-tension glaucoma: treatment to stop glaucomatous cupping and field loss when these progress despite normal intraocular pressure. Ophthalmology. 1982;89:1–6.CrossRefPubMed Abedin S, Simmons RJ, Grant WM. Progressive low-tension glaucoma: treatment to stop glaucomatous cupping and field loss when these progress despite normal intraocular pressure. Ophthalmology. 1982;89:1–6.CrossRefPubMed
6.
Zurück zum Zitat de Jong N, Greve EL, Hoyng PF, Geijssen HC. Results of a filtering procedure in low tension glaucoma. Int Ophthalmol. 1989;13:131–8.CrossRefPubMed de Jong N, Greve EL, Hoyng PF, Geijssen HC. Results of a filtering procedure in low tension glaucoma. Int Ophthalmol. 1989;13:131–8.CrossRefPubMed
8.
Zurück zum Zitat Tezel G, Siegmund KD, Trinkaus K, Trinkaus K, Wax MB, Kass MA, et al. Clinical factors associated with progression of glaucomatous optic disc damage in treated patients. Arch Ophthalmol. 2001;119:813–8.CrossRefPubMed Tezel G, Siegmund KD, Trinkaus K, Trinkaus K, Wax MB, Kass MA, et al. Clinical factors associated with progression of glaucomatous optic disc damage in treated patients. Arch Ophthalmol. 2001;119:813–8.CrossRefPubMed
9.
Zurück zum Zitat Flammer J, Haefliger IO, Orgul S, Resink T. Vascular dysregulation: a principal risk factor for glaucomatous damage? J Glaucoma. 1999;8:212–9.CrossRefPubMed Flammer J, Haefliger IO, Orgul S, Resink T. Vascular dysregulation: a principal risk factor for glaucomatous damage? J Glaucoma. 1999;8:212–9.CrossRefPubMed
10.
Zurück zum Zitat Takebayashi K, Matsumoto S, Aso Y, Inukai T. Aldosterone blockade attenuates urinary monocyte chemoattractant protein-1 and oxidative stress in patients with type 2 diabetes complicated by diabetic nephropathy. J Clin Endocrinol Metab. 2006;91:2214–7.CrossRefPubMed Takebayashi K, Matsumoto S, Aso Y, Inukai T. Aldosterone blockade attenuates urinary monocyte chemoattractant protein-1 and oxidative stress in patients with type 2 diabetes complicated by diabetic nephropathy. J Clin Endocrinol Metab. 2006;91:2214–7.CrossRefPubMed
11.
Zurück zum Zitat Shibata S, Nagase M, Yoshida S, Kawachi H, Fujita T. Podocyte as the target for aldosterone: roles of oxidative stress and Sgk1. Hypertension. 2007;49:355–64.CrossRefPubMed Shibata S, Nagase M, Yoshida S, Kawachi H, Fujita T. Podocyte as the target for aldosterone: roles of oxidative stress and Sgk1. Hypertension. 2007;49:355–64.CrossRefPubMed
12.
Zurück zum Zitat Rossi GP, Sachetto A, Visentin P, Canali C, Graniero GR, Palatini P, et al. Changes in left ventricular anatomy and function in hypertension and primary aldosteronism. Hypertension. 1996;27:1039–45.CrossRefPubMed Rossi GP, Sachetto A, Visentin P, Canali C, Graniero GR, Palatini P, et al. Changes in left ventricular anatomy and function in hypertension and primary aldosteronism. Hypertension. 1996;27:1039–45.CrossRefPubMed
13.
Zurück zum Zitat Halimi J-M, Mimran A. Albuminuria in untreated patients with primary aldosteronism or essential hypertension. J Hypertens. 1995;13:1801–2.PubMed Halimi J-M, Mimran A. Albuminuria in untreated patients with primary aldosteronism or essential hypertension. J Hypertens. 1995;13:1801–2.PubMed
14.
Zurück zum Zitat Takeda R, Matsubara T, Miyamori I, Hatakeyama H, Morise T. Vascular complications in patients with aldosterone producing adenoma in Japan: comparative study with essential hypertension. The Research Committee of Disorders of Adrenal Hormons in Japan. J Endocrinol Invest. 1995;18:370–3.CrossRefPubMed Takeda R, Matsubara T, Miyamori I, Hatakeyama H, Morise T. Vascular complications in patients with aldosterone producing adenoma in Japan: comparative study with essential hypertension. The Research Committee of Disorders of Adrenal Hormons in Japan. J Endocrinol Invest. 1995;18:370–3.CrossRefPubMed
15.
Zurück zum Zitat Nishimura M, Uzu T, Fujii T, Kuroda S, Nakamura S, Inenega T, et al. Cardiovascular complications in patients with primary aldosteronism. Am J Kidney Dis. 1999;33:261–6.CrossRefPubMed Nishimura M, Uzu T, Fujii T, Kuroda S, Nakamura S, Inenega T, et al. Cardiovascular complications in patients with primary aldosteronism. Am J Kidney Dis. 1999;33:261–6.CrossRefPubMed
16.
Zurück zum Zitat Fukuda K, Hirooka K, Mizote M, Nakamura T, Itano T, Shiraga F. Neuroprotection against retinal ischemia-reperfusion injury by blocking the angiotensin II type 1 receptor. Invest Ophthalmol Vis Sci. 2010;51:3629–38.CrossRefPubMed Fukuda K, Hirooka K, Mizote M, Nakamura T, Itano T, Shiraga F. Neuroprotection against retinal ischemia-reperfusion injury by blocking the angiotensin II type 1 receptor. Invest Ophthalmol Vis Sci. 2010;51:3629–38.CrossRefPubMed
17.
Zurück zum Zitat Fujita T, Hirooka K, Nakamura T, Itano T, Nishiyama A, Nagai Y, et al. Neuroprotective effects of angiotensin II type 1 receptor (AT1-R) blocker via modulating AT1-R signaling and decreased extracellular glutamate levels. Invest Ophthalmol Vis Sci. 2012;53:4099–110.CrossRefPubMed Fujita T, Hirooka K, Nakamura T, Itano T, Nishiyama A, Nagai Y, et al. Neuroprotective effects of angiotensin II type 1 receptor (AT1-R) blocker via modulating AT1-R signaling and decreased extracellular glutamate levels. Invest Ophthalmol Vis Sci. 2012;53:4099–110.CrossRefPubMed
18.
Zurück zum Zitat Liu Y, Hirooka K, Nishiyama A, Lei B, Nakamura T, Itano T, et al. Activation of the aldosterone/mineralocorticoid receptor system and protective effects of mineralocorticoid receptor antagonism in retinal ischemia-reperfusion injury. Exp Eye Res. 2012;96:116–23.CrossRefPubMed Liu Y, Hirooka K, Nishiyama A, Lei B, Nakamura T, Itano T, et al. Activation of the aldosterone/mineralocorticoid receptor system and protective effects of mineralocorticoid receptor antagonism in retinal ischemia-reperfusion injury. Exp Eye Res. 2012;96:116–23.CrossRefPubMed
19.
Zurück zum Zitat Wilkinson-Berka JL, Tan G, Jaworski K, Miller AG. Identification of a retinal aldosterone system and the protective effects of mineralocorticoid receptor antagonism on retinal vascular pathology. Circ Res. 2009;104:124–33.CrossRefPubMed Wilkinson-Berka JL, Tan G, Jaworski K, Miller AG. Identification of a retinal aldosterone system and the protective effects of mineralocorticoid receptor antagonism on retinal vascular pathology. Circ Res. 2009;104:124–33.CrossRefPubMed
20.
Zurück zum Zitat Wilkinson-Berka JL, Agrotis A, Deliyanti D. The retinal renin-angiotensin system: role of angiotensin II and aldosterone. Peptides. 2012;36:142–50.CrossRefPubMed Wilkinson-Berka JL, Agrotis A, Deliyanti D. The retinal renin-angiotensin system: role of angiotensin II and aldosterone. Peptides. 2012;36:142–50.CrossRefPubMed
21.
Zurück zum Zitat Nitta E, Hirooka K, Tenkumo K, Fujita T, Nishiyama A, Nakamura T, et al. Aldosterone: a mediator of retinal ganglion cell death and the potential role in the pathogenesis in normal-tension glaucoma. Cell Death Dis. 2013;4:e711.CrossRefPubMedPubMedCentral Nitta E, Hirooka K, Tenkumo K, Fujita T, Nishiyama A, Nakamura T, et al. Aldosterone: a mediator of retinal ganglion cell death and the potential role in the pathogenesis in normal-tension glaucoma. Cell Death Dis. 2013;4:e711.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Rafiq K, Nakano D, Ihara G, Hitomo H, Fujisawa Y, Ohashi N, et al. Effects of mineralocorticoid receptor blockade on glucocorticoid-induced renal injury in adrenalectomized rats. J Hypertens. 2011;29:290–8.CrossRefPubMedPubMedCentral Rafiq K, Nakano D, Ihara G, Hitomo H, Fujisawa Y, Ohashi N, et al. Effects of mineralocorticoid receptor blockade on glucocorticoid-induced renal injury in adrenalectomized rats. J Hypertens. 2011;29:290–8.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Rafiq K, Noma T, Fujisawa Y, Jshihara Y, Arai Y, Nabi AH, et al. Renal sympathetic denervation suppresses de novo podocyte injury and albuminuria in rats with aortic regurgitation. Circulation. 2012;125:1402–13.CrossRefPubMedPubMedCentral Rafiq K, Noma T, Fujisawa Y, Jshihara Y, Arai Y, Nabi AH, et al. Renal sympathetic denervation suppresses de novo podocyte injury and albuminuria in rats with aortic regurgitation. Circulation. 2012;125:1402–13.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Woller G, Brandt E, Mittelstӓdt J, Rybakowski C, Petersen F. Platelet factor 4/CXCL4-stimulated human monocytes induce apoptosis in endothelial cells by the release of oxygen radicals. J Leukoc Biol. 2008;83:936–45.CrossRefPubMed Woller G, Brandt E, Mittelstӓdt J, Rybakowski C, Petersen F. Platelet factor 4/CXCL4-stimulated human monocytes induce apoptosis in endothelial cells by the release of oxygen radicals. J Leukoc Biol. 2008;83:936–45.CrossRefPubMed
25.
Zurück zum Zitat Cohen RA, Vanhoutte PM. Endothelium-dependent hyperpolarization: beyond nitric oxide and cyclic GMP. Circulation. 1995;92:3337–49.CrossRefPubMed Cohen RA, Vanhoutte PM. Endothelium-dependent hyperpolarization: beyond nitric oxide and cyclic GMP. Circulation. 1995;92:3337–49.CrossRefPubMed
26.
Zurück zum Zitat Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA. 1987;84:9265–9.CrossRefPubMedPubMedCentral Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA. 1987;84:9265–9.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Luksch A, Polak K, Beier C. Effects of systemic NO synthase inhibition on choroidal and optic nerve head blood flow in healthy subjects. Invest Ophthalmol Vis Sci. 2000;41:3080–4.PubMed Luksch A, Polak K, Beier C. Effects of systemic NO synthase inhibition on choroidal and optic nerve head blood flow in healthy subjects. Invest Ophthalmol Vis Sci. 2000;41:3080–4.PubMed
28.
Zurück zum Zitat Okuno T, Oku H, Suguyama T, Yang Y, Ikeda T. Evidence that nitric oxide is involved in autoregulation in optic nerve head of rabbits. Invest Ophthalmol Vis Sci. 2002;43:784–9.PubMed Okuno T, Oku H, Suguyama T, Yang Y, Ikeda T. Evidence that nitric oxide is involved in autoregulation in optic nerve head of rabbits. Invest Ophthalmol Vis Sci. 2002;43:784–9.PubMed
29.
Zurück zum Zitat Yamazaki Y, Drance S. The relationship between progression of visual field defects and retrobulbar circulation in patients with glaucoma. Am J Ophthalmol. 1997;124:287–95.CrossRefPubMed Yamazaki Y, Drance S. The relationship between progression of visual field defects and retrobulbar circulation in patients with glaucoma. Am J Ophthalmol. 1997;124:287–95.CrossRefPubMed
30.
Zurück zum Zitat Wang Y, Fawzi A, Varma R, Sadun AA, Zhang X, Tan O, et al. Pilot study of optical coherence tomography measurement of retinal blood flow in retinal and optic nerve diseases. Invest Ophthalmol Vis Sci. 2011;52:840–5.CrossRefPubMedPubMedCentral Wang Y, Fawzi A, Varma R, Sadun AA, Zhang X, Tan O, et al. Pilot study of optical coherence tomography measurement of retinal blood flow in retinal and optic nerve diseases. Invest Ophthalmol Vis Sci. 2011;52:840–5.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Lehmann K, Tschuor C, Rickenbacher A, Jang JH, Oberkofler CE, Tschopp O, et al. Liver failure after extended hepatectomy in mice is mediated by a p21-dependent barrier to liver regeneration. Gastroenterology. 2012;143:1609–19.CrossRefPubMed Lehmann K, Tschuor C, Rickenbacher A, Jang JH, Oberkofler CE, Tschopp O, et al. Liver failure after extended hepatectomy in mice is mediated by a p21-dependent barrier to liver regeneration. Gastroenterology. 2012;143:1609–19.CrossRefPubMed
32.
Zurück zum Zitat Willenbring H, Sharma AD, Vogel A, Lee AY, Rothfuss A, Wang Z, et al. Loss of p21 permits carcinogenesis from chronically damaged liver and kidney epithelial cells despite unchecked apoptosis. Cancer Cell. 2008;14:59–67.CrossRefPubMedPubMedCentral Willenbring H, Sharma AD, Vogel A, Lee AY, Rothfuss A, Wang Z, et al. Loss of p21 permits carcinogenesis from chronically damaged liver and kidney epithelial cells despite unchecked apoptosis. Cancer Cell. 2008;14:59–67.CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Wang DB, Kinoshita C, Kinoshita Y, Morrison RS. P53 and mitochondrial function in neurons. Biochim et Biophys Acta. 2014;1842:1186–97.CrossRef Wang DB, Kinoshita C, Kinoshita Y, Morrison RS. P53 and mitochondrial function in neurons. Biochim et Biophys Acta. 2014;1842:1186–97.CrossRef
34.
Zurück zum Zitat Shi H, Zhang A, He Y, Yang M, Gan W. Effect of p53 on aldosterone-induced mesangial cell apoptosis in vivo and in vitro. Mol Med Rep. 2016;13:5102–8.CrossRefPubMedPubMedCentral Shi H, Zhang A, He Y, Yang M, Gan W. Effect of p53 on aldosterone-induced mesangial cell apoptosis in vivo and in vitro. Mol Med Rep. 2016;13:5102–8.CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Murray-Zmijewski F, Lane DP, Bourdon JC. p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress. Cell Death Differ. 2006;13:962–72.CrossRefPubMed Murray-Zmijewski F, Lane DP, Bourdon JC. p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress. Cell Death Differ. 2006;13:962–72.CrossRefPubMed
36.
Zurück zum Zitat Vousden KH, Prives C. Blinded by the light: the growing complexity of p53. Cell. 2009;137:413–31.CrossRefPubMed Vousden KH, Prives C. Blinded by the light: the growing complexity of p53. Cell. 2009;137:413–31.CrossRefPubMed
37.
Zurück zum Zitat Mason RS, Reichrath J. Sunlight vitamin D and skin cancer. Anticancer Agents Med Chem. 2013;13:83–97.CrossRefPubMed Mason RS, Reichrath J. Sunlight vitamin D and skin cancer. Anticancer Agents Med Chem. 2013;13:83–97.CrossRefPubMed
38.
Zurück zum Zitat Husain K, Ferder L, Mizobuchi M, Finch J, Slatopolsky E. Combination therapy with paricalcitol and enalapril ameliorates cardiac oxidative injury in uremic rats. Am J Nephrol. 2009;29:465–72.CrossRefPubMed Husain K, Ferder L, Mizobuchi M, Finch J, Slatopolsky E. Combination therapy with paricalcitol and enalapril ameliorates cardiac oxidative injury in uremic rats. Am J Nephrol. 2009;29:465–72.CrossRefPubMed
39.
Zurück zum Zitat Rehman S, Chandel N, Salhan D, Rai P, Sharma B, Singh T, et al. Ethanol and vitamin D receptor in T cell apoptosis. J Neuroimmune Pharmacol. 2013;8:251–61.CrossRefPubMed Rehman S, Chandel N, Salhan D, Rai P, Sharma B, Singh T, et al. Ethanol and vitamin D receptor in T cell apoptosis. J Neuroimmune Pharmacol. 2013;8:251–61.CrossRefPubMed
40.
Zurück zum Zitat Zhao M, Valamanesh F, Celerier I, Savoldelli M, Jonet L, Jeanny JC, et al. The neuroretina is a novel mineralocorticoid target: aldosterone up-regulates ion and water channels in Müller glial cells. FASEB J. 2010;24:3405–15.CrossRefPubMed Zhao M, Valamanesh F, Celerier I, Savoldelli M, Jonet L, Jeanny JC, et al. The neuroretina is a novel mineralocorticoid target: aldosterone up-regulates ion and water channels in Müller glial cells. FASEB J. 2010;24:3405–15.CrossRefPubMed
Metadaten
Titel
Gene expression changes in the retina after systemic administration of aldosterone
verfasst von
Aoi Ono
Kazuyuki Hirooka
Yuki Nakano
Eri Nitta
Akira Nishiyama
Akitaka Tsujikawa
Publikationsdatum
30.04.2018
Verlag
Springer Japan
Erschienen in
Japanese Journal of Ophthalmology / Ausgabe 4/2018
Print ISSN: 0021-5155
Elektronische ISSN: 1613-2246
DOI
https://doi.org/10.1007/s10384-018-0595-4

Weitere Artikel der Ausgabe 4/2018

Japanese Journal of Ophthalmology 4/2018 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.